Health status and depression remission in patients with chronic heart failure

Glen Xiong, Mona Fiuzat, Maragatha Kuchibhatla, Ranga Krishnan, Christopher M. O'Connor, Wei Jiang

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Background-Depression is a common comorbidity in heart failure and is strongly associated with increased mortality, morbidity, and reduced health status. Whether depression treatment may result in improvement of health status in heart failure patients with comorbid depression remains unknown. Methods and Results-The Sertraline Against Depression and Heart Disease in Chronic Heart Failure study randomized 469 participants with chronic heart failure (left ventricular ejection fraction 45% and New York Heart Association class II) and major depressive disorder based on Diagnostic Statistics Manual fourth edition criteria to sertraline or placebo for 12 weeks. The Kansas City Cardiomyopathy Questionnaire, 36-Item Short-Form Health Survey, and 6-minute walk test were used to assess health status. Health status changes between treatment arms and remission status were evaluated adjusting for baseline variables and treatment assignment. The final Hamilton Depression Rating Scale scores were 3.50±2.08 and 12.97±4.33 in the remission and nonremission groups, respectively (P value=0.0001). Of 469 total participants, 378 (80.6%) completed the 6-minute walk test and 285 (70.1%) completed Kansas city cardiomyopathy questionnaire and 36-item short-form health survey, at baseline and at week 12. Depression remission was significantly associated with higher improvements in Kansas City Cardiomyopathy Questionnaire subscale scores (P<0.001) except on the Self-Efficacy (P=0.18) and Symptom Stability (P=0.91). On the 36-Item Short-Form Health Survey, depression remission was associated with significant improvement in subscales of the physical and mental component summary except the Pain Index (P=0.34). The 6-minute walk test improved more in depression remission compared with nonremission group (difference from baseline: 63.51±238.78 versus 16.24±115.70 m, P=0.03). Conclusions-Patients with heart failure whose depressive symptoms remitted had significantly greater improvement in physical function, social function, and quality of life.

Original languageEnglish (US)
Pages (from-to)688-692
Number of pages5
JournalCirculation: Heart Failure
Volume5
Issue number6
DOIs
StatePublished - Nov 2012

Fingerprint

Health Status
Heart Failure
Depression
Health Surveys
Cardiomyopathies
Sertraline
Major Depressive Disorder
Self Efficacy
Stroke Volume
Comorbidity
Heart Diseases
Therapeutics
Placebos
Quality of Life
Morbidity
Pain
Mortality
Surveys and Questionnaires
Walk Test

Keywords

  • 6-Minute walk test
  • Depression
  • Health status
  • Heart failure
  • Kansas City Cardiomyopathy Questionnaire

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Xiong, G., Fiuzat, M., Kuchibhatla, M., Krishnan, R., O'Connor, C. M., & Jiang, W. (2012). Health status and depression remission in patients with chronic heart failure. Circulation: Heart Failure, 5(6), 688-692. https://doi.org/10.1161/CIRCHEARTFAILURE.112.967620

Health status and depression remission in patients with chronic heart failure. / Xiong, Glen; Fiuzat, Mona; Kuchibhatla, Maragatha; Krishnan, Ranga; O'Connor, Christopher M.; Jiang, Wei.

In: Circulation: Heart Failure, Vol. 5, No. 6, 11.2012, p. 688-692.

Research output: Contribution to journalArticle

Xiong, G, Fiuzat, M, Kuchibhatla, M, Krishnan, R, O'Connor, CM & Jiang, W 2012, 'Health status and depression remission in patients with chronic heart failure', Circulation: Heart Failure, vol. 5, no. 6, pp. 688-692. https://doi.org/10.1161/CIRCHEARTFAILURE.112.967620
Xiong, Glen ; Fiuzat, Mona ; Kuchibhatla, Maragatha ; Krishnan, Ranga ; O'Connor, Christopher M. ; Jiang, Wei. / Health status and depression remission in patients with chronic heart failure. In: Circulation: Heart Failure. 2012 ; Vol. 5, No. 6. pp. 688-692.
@article{8dfd5577bb684567941f67ab5263b088,
title = "Health status and depression remission in patients with chronic heart failure",
abstract = "Background-Depression is a common comorbidity in heart failure and is strongly associated with increased mortality, morbidity, and reduced health status. Whether depression treatment may result in improvement of health status in heart failure patients with comorbid depression remains unknown. Methods and Results-The Sertraline Against Depression and Heart Disease in Chronic Heart Failure study randomized 469 participants with chronic heart failure (left ventricular ejection fraction 45{\%} and New York Heart Association class II) and major depressive disorder based on Diagnostic Statistics Manual fourth edition criteria to sertraline or placebo for 12 weeks. The Kansas City Cardiomyopathy Questionnaire, 36-Item Short-Form Health Survey, and 6-minute walk test were used to assess health status. Health status changes between treatment arms and remission status were evaluated adjusting for baseline variables and treatment assignment. The final Hamilton Depression Rating Scale scores were 3.50±2.08 and 12.97±4.33 in the remission and nonremission groups, respectively (P value=0.0001). Of 469 total participants, 378 (80.6{\%}) completed the 6-minute walk test and 285 (70.1{\%}) completed Kansas city cardiomyopathy questionnaire and 36-item short-form health survey, at baseline and at week 12. Depression remission was significantly associated with higher improvements in Kansas City Cardiomyopathy Questionnaire subscale scores (P<0.001) except on the Self-Efficacy (P=0.18) and Symptom Stability (P=0.91). On the 36-Item Short-Form Health Survey, depression remission was associated with significant improvement in subscales of the physical and mental component summary except the Pain Index (P=0.34). The 6-minute walk test improved more in depression remission compared with nonremission group (difference from baseline: 63.51±238.78 versus 16.24±115.70 m, P=0.03). Conclusions-Patients with heart failure whose depressive symptoms remitted had significantly greater improvement in physical function, social function, and quality of life.",
keywords = "6-Minute walk test, Depression, Health status, Heart failure, Kansas City Cardiomyopathy Questionnaire",
author = "Glen Xiong and Mona Fiuzat and Maragatha Kuchibhatla and Ranga Krishnan and O'Connor, {Christopher M.} and Wei Jiang",
year = "2012",
month = "11",
doi = "10.1161/CIRCHEARTFAILURE.112.967620",
language = "English (US)",
volume = "5",
pages = "688--692",
journal = "Circulation: Heart Failure",
issn = "1941-3297",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Health status and depression remission in patients with chronic heart failure

AU - Xiong, Glen

AU - Fiuzat, Mona

AU - Kuchibhatla, Maragatha

AU - Krishnan, Ranga

AU - O'Connor, Christopher M.

AU - Jiang, Wei

PY - 2012/11

Y1 - 2012/11

N2 - Background-Depression is a common comorbidity in heart failure and is strongly associated with increased mortality, morbidity, and reduced health status. Whether depression treatment may result in improvement of health status in heart failure patients with comorbid depression remains unknown. Methods and Results-The Sertraline Against Depression and Heart Disease in Chronic Heart Failure study randomized 469 participants with chronic heart failure (left ventricular ejection fraction 45% and New York Heart Association class II) and major depressive disorder based on Diagnostic Statistics Manual fourth edition criteria to sertraline or placebo for 12 weeks. The Kansas City Cardiomyopathy Questionnaire, 36-Item Short-Form Health Survey, and 6-minute walk test were used to assess health status. Health status changes between treatment arms and remission status were evaluated adjusting for baseline variables and treatment assignment. The final Hamilton Depression Rating Scale scores were 3.50±2.08 and 12.97±4.33 in the remission and nonremission groups, respectively (P value=0.0001). Of 469 total participants, 378 (80.6%) completed the 6-minute walk test and 285 (70.1%) completed Kansas city cardiomyopathy questionnaire and 36-item short-form health survey, at baseline and at week 12. Depression remission was significantly associated with higher improvements in Kansas City Cardiomyopathy Questionnaire subscale scores (P<0.001) except on the Self-Efficacy (P=0.18) and Symptom Stability (P=0.91). On the 36-Item Short-Form Health Survey, depression remission was associated with significant improvement in subscales of the physical and mental component summary except the Pain Index (P=0.34). The 6-minute walk test improved more in depression remission compared with nonremission group (difference from baseline: 63.51±238.78 versus 16.24±115.70 m, P=0.03). Conclusions-Patients with heart failure whose depressive symptoms remitted had significantly greater improvement in physical function, social function, and quality of life.

AB - Background-Depression is a common comorbidity in heart failure and is strongly associated with increased mortality, morbidity, and reduced health status. Whether depression treatment may result in improvement of health status in heart failure patients with comorbid depression remains unknown. Methods and Results-The Sertraline Against Depression and Heart Disease in Chronic Heart Failure study randomized 469 participants with chronic heart failure (left ventricular ejection fraction 45% and New York Heart Association class II) and major depressive disorder based on Diagnostic Statistics Manual fourth edition criteria to sertraline or placebo for 12 weeks. The Kansas City Cardiomyopathy Questionnaire, 36-Item Short-Form Health Survey, and 6-minute walk test were used to assess health status. Health status changes between treatment arms and remission status were evaluated adjusting for baseline variables and treatment assignment. The final Hamilton Depression Rating Scale scores were 3.50±2.08 and 12.97±4.33 in the remission and nonremission groups, respectively (P value=0.0001). Of 469 total participants, 378 (80.6%) completed the 6-minute walk test and 285 (70.1%) completed Kansas city cardiomyopathy questionnaire and 36-item short-form health survey, at baseline and at week 12. Depression remission was significantly associated with higher improvements in Kansas City Cardiomyopathy Questionnaire subscale scores (P<0.001) except on the Self-Efficacy (P=0.18) and Symptom Stability (P=0.91). On the 36-Item Short-Form Health Survey, depression remission was associated with significant improvement in subscales of the physical and mental component summary except the Pain Index (P=0.34). The 6-minute walk test improved more in depression remission compared with nonremission group (difference from baseline: 63.51±238.78 versus 16.24±115.70 m, P=0.03). Conclusions-Patients with heart failure whose depressive symptoms remitted had significantly greater improvement in physical function, social function, and quality of life.

KW - 6-Minute walk test

KW - Depression

KW - Health status

KW - Heart failure

KW - Kansas City Cardiomyopathy Questionnaire

UR - http://www.scopus.com/inward/record.url?scp=84873688807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873688807&partnerID=8YFLogxK

U2 - 10.1161/CIRCHEARTFAILURE.112.967620

DO - 10.1161/CIRCHEARTFAILURE.112.967620

M3 - Article

VL - 5

SP - 688

EP - 692

JO - Circulation: Heart Failure

JF - Circulation: Heart Failure

SN - 1941-3297

IS - 6

ER -